- Home
- SOPH vs SLP Comparison
SOPH vs SLP Comparison
Compare SOPH & SLP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SOPH | SLP |
|---|---|---|
| Founded | 2011 | 1996 |
| Country | Switzerland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 330.4M | 322.4M |
| IPO Year | 2021 | 1997 |
Fundamental Metrics
Financial Performance| Metric | SOPH | SLP |
|---|---|---|
| Price | $4.81 | $18.87 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 7 |
| Target Price | $7.00 | ★ $26.80 |
| AVG Volume (30 Days) | 105.6K | ★ 434.1K |
| Earning Date | 11-04-2025 | 01-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $73,297,000.00 | ★ $79,179,000.00 |
| Revenue This Year | $18.32 | $2.02 |
| Revenue Next Year | $15.61 | $6.92 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 13.66 | 13.09 |
| 52 Week Low | $2.58 | $12.39 |
| 52 Week High | $5.30 | $37.67 |
Technical Indicators
Market Signals| Indicator | SOPH | SLP |
|---|---|---|
| Relative Strength Index (RSI) | 55.20 | 54.30 |
| Support Level | $4.54 | $19.11 |
| Resistance Level | $4.84 | $20.06 |
| Average True Range (ATR) | 0.27 | 0.88 |
| MACD | -0.02 | -0.02 |
| Stochastic Oscillator | 42.11 | 53.37 |
Price Performance
Historical ComparisonAbout SOPH SOPHiA GENETICS SA
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.
About SLP Simulations Plus Inc.
Simulations Plus Inc is engaged in the software industry. It includes two segments. It develops and produces software for use in pharmaceutical research and education, and provides consulting and contract research services to the pharmaceutical industry. The company's operating segments include Software and services. The company offers software products for pharmaceutical research such as ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity). It generates maximum revenue from the software segment. Maximum revenue is earned from USA following EMEA and Asia Pacific.